Cargando…

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats

BACKGROUND: Diabetic cardiomyopathy (DCM) is a disorder of the heart muscle in people with diabetes, which is characterized by both systolic and diastolic dysfunction. The effective treatment strategy for DCM has not been developed. METHODS: Rats were divided into 3 groups with different treatment....

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bingong, Zheng, Zeqi, Wei, Yunfeng, Wang, Menghong, Peng, Jingtian, Kang, Ting, Huang, Xin, Xiao, Jian, Li, Yong, Li, Zhe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170868/ https://www.ncbi.nlm.nih.gov/pubmed/21798071 http://dx.doi.org/10.1186/1475-2840-10-69

Ejemplares similares

Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats
por: LI, BINGONG, et al.
Publicado: (2013)

Regulation of TLR4 expression mediates the attenuating effect of erythropoietin on inflammation and myocardial fibrosis in rat heart
por: Liu, Fei, et al.
Publicado: (2018)

Neuregulin-1β Improves Uremic Cardiomyopathy and Renal Dysfunction in Rats
por: Sárközy, Márta, et al.
Publicado: (2023)

Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway
por: Wang, Hongchao, et al.
Publicado: (2022)

Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus
por: Zhang, Lei, et al.
Publicado: (2021)

Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle
por: van den Brom, Charissa E, et al.
Publicado: (2010)

Neuregulin-1, a potential therapeutic target for cardiac repair
por: Wang, Yan, et al.
Publicado: (2022)

Potential Therapeutic Effect of Citronellal on Diabetic Cardiomyopathy in Experimental Rats
por: Lu, Jun-Xiu, et al.
Publicado: (2021)

Diabetic cardiomyopathy: effects of fenofibrate and metformin in an experimental model – the Zucker diabetic rat
por: Forcheron, Fabien, et al.
Publicado: (2009)

Fibroblast growth factor-23 is associated with imaging markers of diabetic cardiomyopathy and anti-diabetic therapeutics
por: Sørensen, Martin H., et al.
Publicado: (2020)

Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways
por: Reinking, Benjamin E, et al.
Publicado: (2009)

Neuregulins in Neurodegenerative Diseases
por: Ou, Guan-yong, et al.
Publicado: (2021)

Rutin alleviates diabetic cardiomyopathy in a rat model of type 2 diabetes
por: WANG, YONG-BIN, et al.
Publicado: (2015)

Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure
por: Odiete, Oghenerukevwe, et al.
Publicado: (2013)

Neuregulin 1: an intriguing therapeutic target for neurodevelopmental disorders
por: Shi, Liang, et al.
Publicado: (2020)

Riboflavin alleviates cardiac failure in Type I diabetic cardiomyopathy
por: Wang, Guoguang, et al.
Publicado: (2011)

Progressive decay of Ca(2+) homeostasis in the development of diabetic cardiomyopathy
por: Zhao, Shu-Mei, et al.
Publicado: (2014)

Autophagy attenuates endothelial-to-mesenchymal transition by promoting Snail degradation in human cardiac microvascular endothelial cells
por: Zou, Jin, et al.
Publicado: (2017)

Rats, Neuregulins and Radical Prostatectomy: A Conceptual Overview
por: Novacescu, Dorin, et al.
Publicado: (2023)

Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid
por: Li, Chun-jun, et al.
Publicado: (2012)

Neuregulin-1 protects cardiac function in septic rats through multiple targets based on endothelial cells
por: Kang, Wen, et al.
Publicado: (2019)

Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway
por: Korkmaz-Icöz, Sevil, et al.
Publicado: (2016)

Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy
por: Wen, He-Ling, et al.
Publicado: (2013)

Phenotyping diabetic cardiomyopathy in Europeans and South Asians
por: Paiman, Elisabeth H. M., et al.
Publicado: (2019)

Plasma Neuregulin 4 Levels Are Associated with Metabolic Syndrome in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Yan, Pijun, et al.
Publicado: (2018)

Pretreatment with neuregulin-1 improves cardiac electrophysiological properties in a rat model of myocardial infarction
por: Rao, Panpan, et al.
Publicado: (2019)

BACE1-Dependent Neuregulin-1 Signaling: An Implication for Schizophrenia
por: Zhang, Zhengrong, et al.
Publicado: (2017)

Impact of the Neuregulin rs35753505 C/T Polymorphisms on Neuregulin 1 Levels in Preterm Infants
por: Lubis, Bugis Mardina, et al.
Publicado: (2019)

Effects of granulocyte-colony stimulating factor (G-CSF) on diabetic cardiomyopathy in Otsuka Long-Evans Tokushima Fatty rats
por: Lim, Young-Hyo, et al.
Publicado: (2011)

Jinmaitong ameliorates diabetic peripheral neuropathy in streptozotocin-induced diabetic rats by modulating gut microbiota and neuregulin 1
por: Xie, Jun, et al.
Publicado: (2020)

Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy
por: Pang, Aiming, et al.
Publicado: (2015)

The Role of Mitochondrial Biogenesis Dysfunction in Diabetic Cardiomyopathy
por: Tao, Li-Chan, et al.
Publicado: (2022)

Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy
por: Sun, Dongdong, et al.
Publicado: (2011)

Proteolytic Processing of Neuregulin 2
por: Czarnek, Maria, et al.
Publicado: (2019)

Altered myocardial substrate metabolism is associated with myocardial dysfunction in early diabetic cardiomyopathy in rats: studies using positron emission tomography
por: van den Brom, Charissa E, et al.
Publicado: (2009)

Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats
por: Zhang, Lin, et al.
Publicado: (2013)

Neuregulin 1 Expression and Electrophysiological Abnormalities in the Neuregulin 1 Transmembrane Domain Heterozygous Mutant Mouse
por: Long, Leonora E., et al.
Publicado: (2015)

MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin
por: Dai, Beibei, et al.
Publicado: (2018)

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
por: Arow, M., et al.
Publicado: (2020)

Effect of Mavacamten on Chinese Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy: The EXPLORER-CN Randomized Clinical Trial
por: Tian, Zhuang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b9csrt0ogntlgocsar946vj5ij